Oropharyngeal Neoplasms
Information
- Disease name
- Oropharyngeal Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02281955 | Active, not recruiting | Phase 2 | De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study | August 2014 | November 2024 |
| NCT00721799 | Completed | Phase 2 | F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients | March 1, 2008 | December 31, 2014 |
| NCT03010813 | Completed | N/A | A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery | December 2016 | October 2017 |
| NCT01104714 | Completed | Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers | April 2010 | July 2014 | |
| NCT03239834 | Completed | Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making | September 7, 2017 | December 20, 2020 | |
| NCT01530997 | Completed | Phase 2 | De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca | February 7, 2012 | November 2019 |
| NCT03077243 | Completed | Phase 2 | P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | December 2016 | December 14, 2022 |
| NCT03074110 | Completed | N/A | Isocapnic Hyperventilation - an Alternative Method | November 11, 2016 | August 15, 2017 |
| NCT02262247 | Completed | A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures | July 2014 | December 2015 | |
| NCT04266093 | Enrolling by invitation | Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies | May 8, 2020 | October 1, 2050 | |
| NCT05412628 | Recruiting | N/A | Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer | March 15, 2022 | February 14, 2024 |
| NCT04124198 | Recruiting | N/A | Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma | March 1, 2019 | January 2029 |
| NCT06167291 | Recruiting | Phase 2 | Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2) | April 19, 2024 | December 9, 2027 |
| NCT02792322 | Recruiting | N/A | Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck | May 2016 | December 2024 |
| NCT02045186 | Terminated | N/A | Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC) | December 2013 | November 2014 |
| NCT01687413 | Terminated | Phase 3 | Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer | January 10, 2013 | October 18, 2019 |
| NCT01525927 | Terminated | Phase 2 | Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity | August 2010 | December 2011 |
| NCT04015336 | Terminated | Phase 2 | E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer | July 6, 2020 | July 15, 2020 |
| NCT00181038 | Unknown status | Phase 3 | Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery | June 2004 | |
| NCT00251381 | Unknown status | Phase 2 | Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. | November 2005 | November 2009 |
| NCT00918710 | Unknown status | Human Papillomavirus and Oropharynx Carcinoma | May 2009 | May 2017 | |
| NCT04044950 | Withdrawn | Phase 2 | A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer | July 29, 2019 | September 17, 2020 |
| NCT02298595 | Withdrawn | Phase 1/Phase 2 | Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma | August 2016 | August 2024 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009959